GCTx named a finalist for the Harvard Innovation Lab’s 2019 President’s Innovation Challenge

“The teams competing in this year’s President’s Innovation Challenge (PIC) represent the extraordinary talent that exists across the University,” said Harvard President Lawrence Bacow GCTx: Revolutionizing cell therapy by building a cell engineering platform that is 100 times faster and 10 times more efficient, enabling customized therapeutics tailored to target hard-to-cure diseases

Learn More

Previous
Previous

Meet the Winners of Harvard Innovation Lab’s Presidential Challenge

Next
Next

Synthetic biology researchers receive the 2018 Massachusetts Life Science Innovation Day prize